CellaVision AB Bearer Shs C26
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €17.26
- Day Range
- €17.24–17.24
- 52-Week Range
- —–—
- Bid/Ask
- €17.30 / €17.52
- Shares Outstanding
- 23.85M
- Market Cap
- €411.20M
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 34.85
- Price/Sales
- 5.89
- Dividend Yield (Trailing)
- 1.47%
- Dividend Yield (Forward)
- 1.47%
- Dividend Payment Schedule
- May
- Total Yield
- 1.47%
Company Profile
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 265
- Website
- https://www.cellavision.com
Valuation
|
Metric
|
C26
|
|---|---|
Price/Earnings (Normalized) | 34.85 |
Price/Book Value | 5.00 |
Price/Sales | 5.89 |
Price/Cash Flow | 22.47 |
Price/Earnings
C26
Financial Strength
|
Metric
|
C26
|
|---|---|
Quick Ratio | 2.62 |
Current Ratio | 3.48 |
Interest Coverage | 73.35 |
Quick Ratio
C26
Profitability
|
Metric
|
C26
|
|---|---|
Return on Assets (Normalized) | 12.23% |
Return on Equity (Normalized) | 15.42% |
Return on Invested Capital (Normalized) | 14.85% |
Return on Assets
C26
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|q^#@v@B | LOCK|yKY% | $191B | |||
| Medtronic PLC
MDT
| LOCK|rZr@@vN | LOCK|s>NK% | $127B | |||
| Stryker Corp
SYK
| LOCK|$?MR&%f | LOCK|$& | $117B | |||
| Boston Scientific Corp
BSX
| LOCK|Y?qCx> | LOCK|@G>> | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|P%&r#cHZ | LOCK|hGyg | $54B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|@>t$!$ | LOCK|t<? | $36B | |||
| DexCom Inc
DXCM
| LOCK|^JXJZj?$ | LOCK|b^$B& | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|cH$ | LOCK|NRc | $27B | |||
| Steris PLC
STE
| LOCK|$@@qF>w | LOCK|H^<h | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|LVjm<DL | LOCK|^F | $19B |
United States